Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy

ClinicalTrials.gov ID: NCT02072161

Public ClinicalTrials.gov record NCT02072161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of ETC-1002 Versus Placebo in Patients With Hypercholesterolemia Receiving Ongoing Statin Therapy

Study identification

NCT ID
NCT02072161
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Esperion Therapeutics, Inc.
Industry
Enrollment
133 participants

Conditions and interventions

Interventions

  • ETC-1002 Drug
  • Placebo Drug
  • Statin Therapy Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2014
Primary completion
Dec 31, 2014
Completion
Dec 31, 2014
Last update posted
Mar 28, 2019

2014 – 2015

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
39
Facility City State ZIP Site status
Not listed Muscle Shoals Alabama 35662
Not listed Chandler Arizona 85224
Not listed Chino California 91710
Not listed Los Angeles California 90057
Not listed Sacramento California 95821
Not listed Walnut Creek California 94595
Not listed Denver Colorado 80220
Not listed Hartford Connecticut 06102
Not listed Brandon Florida 33511
Not listed Jacksonville Florida 32216
Not listed Oviedo Florida 32765
Not listed Ponte Vedra Florida 32081
Not listed Tampa Florida 33606
Not listed West Palm Beach Florida 33409
Not listed Marietta Georgia 30066
Not listed Boise Idaho 83704
Not listed Meridian Idaho 83646
Not listed Evansville Indiana 47714
Not listed Indianapolis Indiana 46260
Not listed Wichita Kansas 67205
Not listed Louisville Kentucky 40213
Not listed Port Gibson Mississippi 39150
Not listed Rochester New York 14609
Not listed Salisbury North Carolina 28144
Not listed Cincinnati Ohio 45219
Not listed Cincinnati Ohio 45245
Not listed Columbus Ohio 43213
Not listed Franklin Ohio 45005
Not listed Lyndhurst Ohio 44124
Not listed Marion Ohio 43302
Not listed Tulsa Oklahoma 74136
Not listed Greer South Carolina 29651
Not listed Mt. Pleasant South Carolina 29464
Not listed Summerville South Carolina 29485
Not listed Kingsport Tennessee 37660
Not listed Houston Texas 77030
Not listed Bountiful Utah 84010
Not listed Orem Utah 84058
Not listed Norfolk Virginia 23502
Not listed Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02072161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02072161 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →